1 Antiretroviral drug-S for a possible HIV elimination.

2 Drug-induced hepatotoxicity among TB/HIV co-infected patients in a referral hospital, Ethiopia.

3 Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges.

4 Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection.

5 Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White Program: the effect of demographic, psychosocial, provider and neighborhood factors.

6 Pre-exposure Prophylaxis in HIV Research: A Latent Dirichlet Allocation Analysis (GAPRESEARCH).

7 A Global Bibliometric Analysis of Services for Children Affected by HIV/AIDS: Implications for Impact Mitigation Programs (GAPRESEARCH).

8 Decision-making in HIV clinical trials: a study with patients enrolled in antiretroviral trials.

9 alopecia areata and vitiligo as primary presentations in a young male with human immunodeficiency virus

10 padrão da infecção pelo hiv/aids em manaus, estado do amazonas, no período de 1986 a 2000 pattern of hiv/aids infection in manaus, state of amazonas, between 1986 and 2000

11 isolation and antigenic characterization of human immunodeficiency virus (hiv) in brazil isolamento e caracterização antigênica do vírus da imunodeficiência humana (vih/hiv) no brasil

12 oral manifestations and related factors of hiv positive patients in south-east of iran

13 meningitis caused by <i> rhodotorula mucilaginosa </i> in human immunodeficiency virus seropositive patient

14 effect of antiretroviral therapy on changes in the fertility intentions of human immunodeficiency virus-positive women in addis ababa, ethiopia: a prospective follow-up study

15 rheumatoid arthritis in patients with hiv: management challenges

16 rehabilitación fisioterapéutica de personas viviendo con el virus de inmunodeficiencia humana y sida physiotherapeutic rehabilitation of people with hiv/aids

17 evaluation of the therapeutic response of hepatitis c in coinfected patients (hiv/hcv): a study of cases from a hospital for chronic liver diseases in the eastern brazilian amazon

18 miliary tuberculosis coinfection with the human immunodeficiency virus

19 opportunistic and non-opportunistic intestinal parasites in hiv/ aids patients in relation to their clinical and epidemiological status in a specialized medical service in goiás, brazil

20 new drug resistance mutations of reverse transcriptase human immunodeficiency virus type-1 gene in first-line antiretroviral-infected patients in west sumatra, indonesia

21 review of cardiovascular magnetic resonance in human immunodeficiency virus-associated cardiovascular disease

22 radiology of hiv/aids in china: current status and clinical application

23 the potential anesthetic threats, challenges and intensive care considerations in patients with hiv infection

24 detection of opportunistic dna viral infections by multiplex pcr among hiv infected individuals receiving care at a tertiary care hospital in south india

25 palliative medicine and people

26 monocytic myeloid-derived suppressor cells in chronic infections

27 herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection

28 a cross section study to determine the prevalence of antibodies against hiv infection among hepatitis b and c infected individuals

29 cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis

30 atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in southeast nigeria

31 human immunodeficiency virus endocrinopathy

32 antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the central public health laboratory, são paulo, brazil: preliminary results

33 mucosal-associated invariant t cells in regenerative medicine

34 intermittent versus continuous androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

35 Script Generation of Activities of Daily Living in HIV-Associated Neurocognitive Disorders

36 Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

37 Tualang honey ameliorates viral load, CD4 counts and improves quality of life in asymptomatic human immunodeficiency virus infected patients

38 Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy.

39 A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

40 The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa

41 Safe Water and Hygiene Integration with Human Immunodeficiency Virus and Antenatal Services: Leveraging Opportunities for Public Health Interventions and Improved Service Uptake.

42 Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

43 Alchemy: A web 2.0 real-time quality assurance platform for human immunodeficiency Virus, hepatitis C Virus, and BK Virus quantitation assays

44 Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial.

45 Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.

46 Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis.

47 Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

48 The relationship between alcohol use and anxiety and retrospective attendance of primary care visits among women with human immunodeficiency virus

49 Distúrbios de leitura e escrita em portadora do vírus da imunodeficiência humana: estudo de caso Reading and writing disorders in a patient with the human immunodeficiency virus: a case study

50 Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.

51 Experiences of women enrolled in a prevention of mother to child transmission of human immunodeficiency virus infection programme in Zimbabwe.

52 Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon

53 Human immunodeficiency virus type-1 Tat protein induces secretory leukocyte protease inhibitor expression in African green monkey but not human cells.

54 Disseminated Masquerading as Pulmonary Tuberculosis in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome.

55 Male involvement in prevention of mother to child transmission of human immunodeficiency virus and associated factors in Enebsiesarmider District, north West Ethiopia, 2018: a cross-sectional study.

56 Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review

57 Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus

58 Subclinical Vascular Disease in Children With Human Immunodeficiency Virus in Uganda Is Associated With Intestinal Barrier Dysfunction

59 Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study

60 Exercise and Vitamin E Intake Are Independently Associated with Metabolic Abnormalities in Human Immunodeficiency Virus—Positive Subjects: A Cross-Sectional Study

61 Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance

62 Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)

63 Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia

64 Effect of Dietary Intake and Protease Inhibitors on Serum Vitamin B12 Levels in a Cohort of Human Immunodeficiency Virus—Positive Patients

65 Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study

66 Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group

67 Intestinal mucosal inflammation associated with human immunodeficiency virus infection

68 The impact of active herpes simplex virus infection on human immunodeficiency virus load

69 Human Immunodeficiency Virus Infection in Patients with Solid-Organ Transplants: Report of Five Cases and Review

70 Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother–Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe

71 Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence

72 Spectrum of Disease in Persons With Human Immunodeficiency Virus Infection in the United States

73 Zinc Status in Human Immunodeficiency Virus Type 1 Infection and Illicit Drug Use

74 Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

75 Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001–2015

76 Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

77 Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children

78 Diverse and High Prevalence of Human Papillomavirus Associated with a Significant High Rate of Cervical Dysplasia in Human Immunodeficiency Virus–Infected Women in Johannesburg, South Africa

79 Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites

80 Clinical Efficacy of High-Dose Acyclovir in Patients with Human Immunodeficiency Virus Infection: A Meta-Analysis of Randomized Individual Patient Data

81 Respiratory syncytial virus infection in human immunodeficiency virus-infected children

82 Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

83 Human Herpesvirus 8-Associated Hemophagocytic Lymphohistiocytosis in Human Immunodeficiency Virus-Infected Patients

84 Mortality, Human Immunodeficiency Virus (HIV) Transmission, and Growth in Children Exposed to HIV in Rural Zimbabwe

85 Enteric Infections and Diarrhea in Human Immunodeficiency Virus–Infected Persons: Prospective Community-Based Cohort Study

86 Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases: A Randomized Controlled Trial

87 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and re-vaccination

88 Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1

89 Interactions of the Human Immunodeficiency Virus and Tuberculosis and the Implications for BCG Vaccination

90 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

91 In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses

92 Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

93 Spectrum of disease in persons with human immunodeficiency virus infection in the United States

94 Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire

95 Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire

96 Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy

97 Dietary Habits and Their Association with Metabolic Abnormalities in Human Immunodeficiency Virus—Related Lipodystrophy

98 Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men

99 Herpes Simplex Virus Infection as a Risk Factor for Human Immunodeficiency Virus Infection in Heterosexuals

100 Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

101 Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

Keyword Connections

Journals

Research Groups

Bibliographies